Shares in pharmaceuticals giant AstraZeneca have surged 6% after it started testing whether its Calquence drug can help treat severely ill Covid-19 patients. Calquence is a blood cancer treatment - it inhibits an enzyme called Bruton’s tyrosine kinase which helps some leukemic cells to survive and proliferate .
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:
Let shorts live in China... this farse must end. The economy will hard land
ENOUGH WITH THE FUCKING VIRUS, IT'S A TIDDLER
The best time to start your online business at home now. You don’t need a home business plan. You need to learn how to set up one and manage it. 📊💵 Read more 👇✅
We, and many other people won’t be buying anything from China in future.